RAGE and its ligands: a lasting memory in diabetic complications? (Q36320548)

13 August 2017

1 reference

title

RAGE and its ligands: a lasting memory in diabetic complications? (English)

1 reference

13 August 2017

12

Ann Marie Schmidt

1 reference

13 August 2017

Shi-Fang Yan

1

1 reference

13 August 2017

Ravichandran Ramasamy

2

1 reference

13 August 2017

Loredana G Bucciarelli

3

1 reference

13 August 2017

Thoralf Wendt

4

1 reference

13 August 2017

Larisse K Lee

5

1 reference

13 August 2017

Barry I Hudson

6

1 reference

13 August 2017

David M Stern

7

1 reference

13 August 2017

Evanthia Lalla

8

1 reference

13 August 2017

Shi DU Yan

9

1 reference

13 August 2017

Ling Ling Rong

10

1 reference

13 August 2017

Yoshifumi Naka

11

1 reference

13 August 2017

language of work or name

English

0 references

publication date

1 May 2004

1 reference

Diabetes and Vascular Disease Research

13 August 2017

published in

1 reference

13 August 2017

volume

1

1 reference

13 August 2017

issue

1

1 reference

13 August 2017

page(s)

10-20

1 reference

Diabetes and cardiovascular disease. The Framingham study

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2004.001

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2004.001

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2004.001

Intensive diabetes therapy and carotid intima-media thickness in type 1 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2004.001

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2004.001

Glycation products and the pathogenesis of diabetic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2004.001

Immunohistochemical colocalization of glycoxidation products and lipid peroxidation products in diabetic renal glomerular lesions. Implication for glycoxidative stress in the pathogenesis of diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2004.001

Advanced Maillard reaction end products are associated with Alzheimer disease pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2004.001

Increased accumulation of the glycoxidation product N(epsilon)-(carboxymethyl)lysine in human tissues in diabetes and aging.

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2004.001

In vitro formation of N(epsilon)-(carboxymethyl)lysine and imidazolones under conditions similar to continuous ambulatory peritoneal dialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2004.001

The myeloperoxidase system of human phagocytes generates Nepsilon-(carboxymethyl)lysine on proteins: a mechanism for producing advanced glycation end products at sites of inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2004.001

N (epsilon)-(carboxymethyl)lysine protein adduct is a major immunological epitope in proteins modified with advanced glycation end products of the Maillard reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2004.001

N-epsilon-(carboxyethyl)lysine, a product of the chemical modification of proteins by methylglyoxal, increases with age in human lens proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2004.001

N(epsilon)-(carboxymethyl)lysine adducts of proteins are ligands for receptor for advanced glycation end products that activate cell signaling pathways and modulate gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2004.001

Molecular identity and cellular distribution of advanced glycation endproduct receptors: relationship of p60 to OST-48 and p90 to 80K-H membrane proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2004.001

RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2004.001

Receptor for advanced glycation end products (RAGE)-mediated neurite outgrowth and activation of NF-kappaB require the cytoplasmic domain of the receptor but different downstream signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2004.001

Central role of RAGE-dependent neointimal expansion in arterial restenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2004.001

Regulation of human mononuclear phagocyte migration by cell surface-binding proteins for advanced glycation end products

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2004.001

Advanced glycation endproducts interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice. A potential mechanism for the accelerated vasculopathy of dia

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2004.001

The receptor for advanced glycation end products (RAGE) is a central mediator of the interaction of AGE-beta2microglobulin with human mononuclear phagocytes via an oxidant-sensitive pathway. Implications for the pathogenesis of dialysis-related amyl

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2004.001

Beta 2-microglobulin modified with advanced glycation end products modulates collagen synthesis by human fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2004.001

Characterization and functional analysis of the promoter of RAGE, the receptor for advanced glycation end products

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2004.001

The S100 family of EF-hand calcium-binding proteins: functions and pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2004.001

The S100 protein family: history, function, and expression

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2004.001

S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2004.001

RAGE and arthritis: the G82S polymorphism amplifies the inflammatory response

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2004.001

Suppression of experimental autoimmune encephalomyelitis by selective blockade of encephalitogenic T-cell infiltration of the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2004.001

Receptor for advanced glycation end products mediates inflammation and enhanced expression of tissue factor in vasculature of diabetic apolipoprotein E-null mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2004.001

RAGE drives the development of glomerulosclerosis and implicates podocyte activation in the pathogenesis of diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2004.001

The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin. Mediation of neurite outgrowth and co-expression of rage and amphoterin in the developing nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2004.001

The adhesive and neurite-promoting molecule p30: analysis of the amino-terminal sequence and production of antipeptide antibodies that detect p30 at the surface of neuroblastoma cells and of brain neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2004.001

HMG-1 as a late mediator of endotoxin lethality in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2004.001

High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2004.001

High mobility group box chromosomal protein 1, a DNA binding cytokine, induces arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2004.001

The pattern recognition receptor (RAGE) is a counterreceptor for leukocyte integrins: a novel pathway for inflammatory cell recruitment

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2004.001

Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilatation in experimental diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2004.001

Impaired endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2004.001

Receptor-mediated endothelial cell dysfunction in diabetic vasculopathy. Soluble receptor for advanced glycation end products blocks hyperpermeability in diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2004.001

The receptor RAGE as a progression factor amplifying arachidonate-dependent inflammatory and proteolytic response in human atherosclerotic plaques: role of glycemic control

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2004.001

Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2004.001

Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2004.001

Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2004.001

RAGE blockade stabilizes established atherosclerosis in diabetic apolipoprotein E-null mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2004.001

A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2004.001

Sirolimus-Eluting Stents versus Standard Stents in Patients with Stenosis in a Native Coronary Artery

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2004.001

Coronary restenosis after sirolimus-eluting stent implantation: morphological description and mechanistic analysis from a consecutive series of cases

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2004.001

Drug-eluting stents and glycoprotein IIb/IIIa inhibitors: Combination therapy for the future

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2004.001

Receptor for AGE (RAGE) mediates neointimal formation in response to arterial injury

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2004.001

Role of receptor for advanced glycation end-product (RAGE) and the JAK/STAT-signaling pathway in AGE-induced collagen production in NRK-49F cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2004.001

Morbidity and mortality in diabetics in the Framingham population. Sixteen year follow-up study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2004.001

Cardiac consequences of diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2004.001

Plasma 3-deoxyglucosone elevation in chronic renal failure is associated with increased aldose reductase in erythrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2004.001

Relation between serum 3-deoxyglucosone and development of diabetic microangiopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2004.001

Alterations in behavior, amyloid beta-42, caspase-3, and Cox-2 in mutant PS2 transgenic mouse model of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2004.001

Aldose reductase inhibition protects diabetic and nondiabetic rat hearts from ischemic injury

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2004.001

Requirement for p38 and p44/p42 mitogen-activated protein kinases in RAGE-mediated nuclear factor-kappaB transcriptional activation and cytokine secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2004.001

A redox-triggered ras-effector interaction. Recruitment of phosphatidylinositol 3'-kinase to Ras by redox stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2004.001

Activation of the receptor for advanced glycation end products triggers a p21(ras)-dependent mitogen-activated protein kinase pathway regulated by oxidant stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2004.001

Receptor for advanced glycation end products (RAGE) signaling induces CREB-dependent chromogranin expression during neuronal differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2004.001

Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-κB

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2004.001

Blockade of RAGE suppresses periodontitis-associated bone loss in diabetic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2004.001

Pimagedine: a novel therapy for diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2004.001

Therapeutic potential of breakers of advanced glycation end product–protein crosslinks

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2004.001

Blockade of receptor for advanced glycation end-products restores effective wound healing in diabetic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2004.001

Blockade of RAGE–amphoterin signalling suppresses tumour growth and metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2004.001

21 January 2018

Identifiers

DOI

10.3132/DVDR.2004.001

1 reference

13 August 2017

1 reference